[Inhibition of anti-tumor immunity by NF-κB: Toward therapeutic targeting?]
Med Sci (Paris)
.
2022 Feb;38(2):230-232.
doi: 10.1051/medsci/2022013.
Epub 2022 Feb 18.
[Article in French]
Authors
Lara Revol-Bauz
1
,
Yenkel Grinberg-Bleyer
2
Affiliations
1
Master de cancérologie, module d'immunologie - virologie, université Claude Bernard Lyon 1, Lyon, France.
2
Centre de recherche en cancérologie de Lyon, UMR Inserm 1052, CNRS 5286, centre Léon Bérard, université Claude Bernard Lyon 1, Lyon, France.
PMID:
35179482
DOI:
10.1051/medsci/2022013
No abstract available
Publication types
News
MeSH terms
Cell Line, Tumor
Humans
NF-kappa B*
Substances
NF-kappa B